Ocean Biomedical, Inc.

Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharmaceutical company focused on developing treatments across oncology, infectious disease, and fibrotic conditions, with scientific foundations tied to research from Brown University. The company pursued public markets through a de-SPAC business combination with Aesther Healthcare Acquisition Corp, which traded on Nasdaq under the ticker AEHA and completed its IPO in 2021 targeting the healthcare sector. An 8-K filed with the SEC on October 5, 2022, under accession number 0001493152-22-027656, disclosed material developments related to the pending transaction, which subsequently closed in early 2023. The combined entity operates in the life sciences and biopharmaceutical space. Sign up at SpacDesk for full filing history, sponsor data, and real-time SPAC analytics.